The global Infectious Disease Molecular Diagnostics Market was valued at around USD 34 billion in 2021.
With a projected CAGR of 4.2% for the next ten years, the market is likely to reach a valuation of nearly USD 53 billion by the end of 2032. Developers are increasingly relying on scientific developments from a variety of fields rather than the traditional methods that required the culture of the pathogens. Molecular diagnostics is one of the fields in infectious Disease identification that is expanding the fastest.
| Report Attributes | Details |
|---|---|
| Infectious Disease Molecular Diagnostics Market Size (2021A) | USD 34.0 billion |
| Estimated Market Value (2022E) | USD 35 billion |
| Forecasted Market Value (2032F) | USD 53 billion |
| Global Market Growth Rate (2022 to 2032) | 4.2% CAGR |
| United States Growth Rate (2022 to 2032) | 4.3% CAGR |
| Key Companies Covered | Abbott; Danaher Corporation; bioMérieux SA; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Becton, Dickinson, and Company; Hologic, Inc. (Gen-Probe); Illumina, Inc.; Grifols S.A.; Qiagen; Siemens Healthineers AG; Sysmex Corporation |
The global market for the Infectious Disease Molecular Diagnostics Market expanded at a CAGR of 3.8% over the last four years (2017 to 2021). Future Market Insights’ analysis reveals that in 2022 revenue through the market is estimated at USD 39.5 billion. With an absolute dollar opportunity of USD 18 billion from 2022 to 2032, the market is projected to reach a valuation of USD 53 billion by 2032.
The USA will continue to be the largest consumer of the Infectious Disease Molecular Diagnostics Market throughout the analysis period accounting for over USD 5.8 billion absolute dollar opportunity in the coming 10-year period
Global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated researchers to develop rapid and accurate detection methods for pathogens. Culture-based techniques are considered gold standards for pathogen detection globally.
However, the long result time associated with these techniques due to overnight culturing and limited pathogen isolation has slowed their demand to a certain extent. Over the past several years, innovations in molecular diagnostic technology and their use have fundamentally altered the ability to handle infectious diseases. It provides quicker and more reliable results at 30% less cost to the customers.
Although still in its infancy, pharmacogenomics has the potential to grow into a rich industry as demand for tailored medication rises. As the driving force behind the transition to personalized medicine, many pharmaceutical companies are assessing revenue models based on molecular diagnostics for pharmacogenomics testing.
One of the key factors limiting the growth of the infectious disease molecular diagnostics market is inadequate reimbursements. The hurdles to getting Medicare insurance to pay for diagnostic tests are a significant concern for diagnostic organizations.
In 2018, Medicare in the USA tightened constraints on I.V.D. diagnostic claims, which affected molecular diagnostic tests in particular. These molecular pathology tests might be billed using unlisted medical codes rather than the American Medical Association's Current Procedural Terminology (CPT) numbers. Medicare Administrative Contractors (MACs) set the allowable cost amount for the billing locality in these cases.
The entirety of the clinical lab will gradually be expected to execute molecular diagnostics testing on a regular basis. Venture capitalists, who formerly preferred not to make investments in this area, will progressively grow more enthusiastic about investing in molecular diagnostic businesses as the field of molecular diagnostics progresses.
The American Cancer Society estimates that there will be 1.7 million new instances of cancer in the US this year and more than 606 thousand cancer-related deaths. Therefore, it is predicted that over the forecast period, the demand for molecular diagnostics would expand due to the rising incidence of cancer and increased public awareness of the importance of early cancer detection.
The development and global distribution agreement for molecular testing in Mexico to find new sexually-transmitted infections were announced by Becton Dickinson and Euroclone in February 2019. The market is projected to expand in the future due to rising diseases and innovation in North America.
The USA will account for over USD 16.9 billion of the global market by 2032. 6 out of 10 of America's adults have a chronic disease, and 4 out of 10 people have two or more diseases. , as of January 2021, according to a report made public by the National Center for Chronic Disease Prevention and Health Promotion.
The US FDA had received emergency use authorization requests from Becton, Dickinson, and Company, and BioGX Inc. for novel diagnostic tests, the two businesses announced in March 2020.
The market in the UK is expected to reach USD 2.2 billion, growing from USD 1.5 billion in 2021. The market in the country is projected to expand at a CAGR of 3.5% from 2022 to 2032, and prosper with an absolute dollar opportunity of USD 644 million.
The market in Japan is expected to gross an absolute dollar opportunity of USD 981 million from 2022 to 2032. During this period, the market is projected to register a CAGR of 5.9% to reach a market size of USD 2.3 billion by 2032.
The market in South Korea is expected to gross an absolute dollar opportunity of USD 400 million from 2022 to 2032. The market is likely to reach a valuation of USD 1.1 billion by 2032.
The Polymerase Chain Reaction (PCR) segment account for over 30% of the technology category of the global Infectious Disease Molecular Diagnostics Market. The market growth from 2017 to 2021 was estimated at 4.4% CAGR. A qualitative outcome of a PCR investigation may be required for the detection of genetic polymorphisms, inherited disorders, somatic mutations, including cancer, and the presence of viral or microbial infections.
Quantitative PCR is increasingly needed, for instance, to assess a pathogen's titer, the quantity of infected or altered cells in a tissue, and the concentration of particular mRNAs.
PCR has several uses in medicine, including tissue typing for organ and tissue transplants. Commercially, HLA DQa locus analysis kits are currently readily available. The application of PCR for forensic purposes is associated with this application. The PCR can use this area, in particular, to take advantage of its extreme sensitivity.
At present, many diagnostics firms that were under-represented in this area have sought partners or acquisitions to gain exposure, reflecting the growing interest in personalized medicine.
The key companies operating in the market include F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Siemens Healthineers AG, Danaher Corporation, Illumina, Inc., Becton Dickinson and Company, Grifols, S.A., Quidel Corporation, Agilent Technologies, Inc., DiaSorin S.p.a. (Italy), Exact Sciences Corporation, Genetic Signatures, MDx Health, Biocartis NV, TBG Diagnostics Limited, HTG Molecular Diagnostics, Inc., Vela Diagnostics, Amoy Diagnostics Co., Ltd., ELITechGroup, Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, Abacus Diagnostica Oy, and geneOmbio Technologies Pvt. Ltd.
Some of the recent developments by key providers of Infectious Disease Molecular Diagnostics are as follows:
Similarly, recent developments related to companies manufacturing infectious disease molecular diagnostics kits have been tracked by the team at Future Market Insights, which is available in the full report.
Table 1: Global Market Value (US$ billion) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 3: Global Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 4: Global Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 5: Global Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 6: North America Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 7: North America Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 8: North America Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 9: North America Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 10: North America Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 11: Latin America Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 12: Latin America Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 13: Latin America Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 14: Latin America Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 15: Latin America Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 16: Europe Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 17: Europe Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 18: Europe Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 19: Europe Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 20: Europe Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 21: Asia Pacific Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 22: Asia Pacific Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 23: Asia Pacific Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 24: Asia Pacific Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 25: Asia Pacific Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Table 26: MEA Market Value (US$ billion) Forecast by Country, 2017 to 2032
Table 27: MEA Market Value (US$ billion) Forecast by Application, 2017 to 2032
Table 28: MEA Market Value (US$ billion) Forecast by Product Type, 2017 to 2032
Table 29: MEA Market Value (US$ billion) Forecast by Test Location, 2017 to 2032
Table 30: MEA Market Value (US$ billion) Forecast by Technology, 2017 to 2032
Figure 1: Global Market Value (US$ billion) by Application, 2022 to 2032
Figure 2: Global Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 3: Global Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 4: Global Market Value (US$ billion) by Technology, 2022 to 2032
Figure 5: Global Market Value (US$ billion) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ billion) Analysis by Region, 2017 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 9: Global Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 12: Global Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 15: Global Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 18: Global Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 21: Global Market Attractiveness by Application, 2022 to 2032
Figure 22: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 23: Global Market Attractiveness by Test Location, 2022 to 2032
Figure 24: Global Market Attractiveness by Technology, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ billion) by Application, 2022 to 2032
Figure 27: North America Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 28: North America Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 29: North America Market Value (US$ billion) by Technology, 2022 to 2032
Figure 30: North America Market Value (US$ billion) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 37: North America Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 40: North America Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 43: North America Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 46: North America Market Attractiveness by Application, 2022 to 2032
Figure 47: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 48: North America Market Attractiveness by Test Location, 2022 to 2032
Figure 49: North America Market Attractiveness by Technology, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ billion) by Application, 2022 to 2032
Figure 52: Latin America Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 53: Latin America Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 54: Latin America Market Value (US$ billion) by Technology, 2022 to 2032
Figure 55: Latin America Market Value (US$ billion) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 62: Latin America Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 65: Latin America Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 68: Latin America Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Test Location, 2022 to 2032
Figure 74: Latin America Market Attractiveness by Technology, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ billion) by Application, 2022 to 2032
Figure 77: Europe Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 78: Europe Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 79: Europe Market Value (US$ billion) by Technology, 2022 to 2032
Figure 80: Europe Market Value (US$ billion) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 87: Europe Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 90: Europe Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 93: Europe Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 96: Europe Market Attractiveness by Application, 2022 to 2032
Figure 97: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 98: Europe Market Attractiveness by Test Location, 2022 to 2032
Figure 99: Europe Market Attractiveness by Technology, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: Asia Pacific Market Value (US$ billion) by Application, 2022 to 2032
Figure 102: Asia Pacific Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 103: Asia Pacific Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 104: Asia Pacific Market Value (US$ billion) by Technology, 2022 to 2032
Figure 105: Asia Pacific Market Value (US$ billion) by Country, 2022 to 2032
Figure 106: Asia Pacific Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: Asia Pacific Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 112: Asia Pacific Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 115: Asia Pacific Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 118: Asia Pacific Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 121: Asia Pacific Market Attractiveness by Application, 2022 to 2032
Figure 122: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 123: Asia Pacific Market Attractiveness by Test Location, 2022 to 2032
Figure 124: Asia Pacific Market Attractiveness by Technology, 2022 to 2032
Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 126: MEA Market Value (US$ billion) by Application, 2022 to 2032
Figure 127: MEA Market Value (US$ billion) by Product Type, 2022 to 2032
Figure 128: MEA Market Value (US$ billion) by Test Location, 2022 to 2032
Figure 129: MEA Market Value (US$ billion) by Technology, 2022 to 2032
Figure 130: MEA Market Value (US$ billion) by Country, 2022 to 2032
Figure 131: MEA Market Value (US$ billion) Analysis by Country, 2017 to 2032
Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: MEA Market Value (US$ billion) Analysis by Application, 2017 to 2032
Figure 135: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 136: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 137: MEA Market Value (US$ billion) Analysis by Product Type, 2017 to 2032
Figure 138: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 139: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 140: MEA Market Value (US$ billion) Analysis by Test Location, 2017 to 2032
Figure 141: MEA Market Value Share (%) and BPS Analysis by Test Location, 2022 to 2032
Figure 142: MEA Market Y-o-Y Growth (%) Projections by Test Location, 2022 to 2032
Figure 143: MEA Market Value (US$ billion) Analysis by Technology, 2017 to 2032
Figure 144: MEA Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 145: MEA Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 146: MEA Market Attractiveness by Application, 2022 to 2032
Figure 147: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 148: MEA Market Attractiveness by Test Location, 2022 to 2032
Figure 149: MEA Market Attractiveness by Technology, 2022 to 2032
Figure 150: MEA Market Attractiveness by Country, 2022 to 2032
The global Infectious Disease Molecular Diagnostics Market was valued at USD 34 billion in 2021.
The Infectious Disease Infectious Disease Molecular Diagnostics Market is set to witness a growth rate of 4.2% over the forecast period and be valued at USD 53 billion by 2032.
The Infectious Disease Infectious Disease Molecular Diagnostics Market expanded by 3.7% from 2017 through 2021.
The key players BD, BioMérieux SA, Bio-Rad Laboratories Inc., Abbott, and Agilent Technologies Inc. are shaping the Infectious Disease Molecular Diagnostics Market.
United States, United Kingdom, China, Japan, and South Korea are expected to drive the most sales growth in the Infectious Disease Molecular Diagnostics Market.
Explore In-vitro Diagnostics Devices Insights
Infectious Disease Molecular Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
